Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -47.070% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1ccc(-c2ccc(N3CCOCC3)nn2)cc1
b.) CCOc1ccc(NC(=O)NCCN2C(C)CCCC2C)cc1
c.) O=[N+]([O-])c1ccc(NCc2ccccn2)nc1
Answer: a. Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1ccc(-c2ccc(N3CCOCC3)nn2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1ccc(-c2ccc(N3CCOCC3)nn2)cc1
Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)Nc1ccc(-c2ccc(N3CCOCC3)nn2)cc1
[4-methyl-3-[[4-(6-morpholin-4-ylpyridazin-3-yl)phenyl]sulfamoyl]phenyl]-oxido-oxoazanium